Maze Therapeutics, Inc. (MAZE): SCHEDULE 13G filed Feb 7, 2025

Form type

SCHEDULE 13G

Filing date

Feb 7, 2025

Accession number

0001104659-25-010521

Filer

Maze Therapeutics, Inc. (CIK 1842295)